CardieX Limited Stock

Equities

CDX

AU0000015729

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:59:40 2024-04-19 am EDT 5-day change 1st Jan Change
0.071 AUD 0.00% Intraday chart for CardieX Limited -4.05% -47.41%
Sales 2024 * 10.9M 7M Sales 2025 * 17.6M 11.31M Capitalization 20.89M 13.42M
Net income 2024 * -8M -5.14M Net income 2025 * -3M -1.93M EV / Sales 2024 * 2.11 x
Net Debt 2024 * 2.1M 1.35M Net Debt 2025 * 2M 1.28M EV / Sales 2025 * 1.3 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 92.07%
More Fundamentals * Assessed data
Dynamic Chart
1 week-4.05%
Current month-6.58%
1 month-11.25%
3 months-12.35%
6 months-12.35%
Current year-47.41%
More quotes
1 week
0.07
Extreme 0.07
0.08
1 month
0.07
Extreme 0.07
0.08
Current year
0.07
Extreme 0.07
0.10
1 year
0.07
Extreme 0.07
0.42
3 years
0.07
Extreme 0.07
1.00
5 years
0.07
Extreme 0.07
1.15
10 years
0.07
Extreme 0.07
3.45
More quotes
Managers TitleAgeSince
Founder - 93-12-31
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - 20-04-30
Members of the board TitleAgeSince
Director/Board Member 67 15-11-12
Founder - 93-12-31
Founder 60 93-12-31
More insiders
Date Price Change Volume
24-04-19 0.071 0.00% 665 672
24-04-18 0.071 -1.39% 662,329
24-04-17 0.072 -1.37% 307,932
24-04-16 0.073 -2.67% 314,474
24-04-15 0.075 +1.35% 186,615

Delayed Quote Australian S.E., April 19, 2024 at 01:59 am EDT

More quotes
CardieX Limited is an Australia-based health technology company. It is engaged in designing, manufacturing, and marketing medical devices for use in cardiovascular health management, and the development of clinical and consumer digital health solutions. It is focused on hypertension, cardiovascular disease, and other vascular health disorders. It operates through its subsidiaries, including ATCOR and CONNEQT. ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its SphygmoCor technology. Under the ATCOR.X brand, it also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. Its digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients’ health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness parameters.
More about the company

Annual profits - Rate of surprise